Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma, Ovarian Epithelial × durvalumab × Clear all

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 13 Small Cell Lung Carcinoma 8 Head and Neck Neoplasms 6 Carcinoma, Hepatocellular 6 Lung Neoplasms 5 Urinary Bladder Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Melanoma 4 Rectal Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Biliary Tract Neoplasms 3 Stomach Neoplasms 2 Recurrence 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Lymphoma 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Renal Cell 2 Carcinoma, Merkel Cell 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Unresectable Stage III NSCLC 1 Triple Negative Breast Neoplasms 1 Resectable Biliary Tract Cancer 1 Platinum-resistant Recurrent Ovarian Cancer 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1

Interventions

Carboplatin 15 Paclitaxel 13 olaparib 4 Hyperthermic Intraperitoneal Chemotherapy 4 Cisplatin 4 oregovomab 3 Topotecan 3 Gemcitabine 3 Docetaxel 3 Cyclophosphamide 3 Chemotherapy, Adjuvant 3 Amplified Fragment Length Polymorphism Analysis 3 niraparib 2 liposomal doxorubicin 2 ST 1481 2 Radiotherapy 2 Neoadjuvant Therapy 2 Immunohistochemistry 2 Gene Expression Profiling 2 Flow Cytometry 2 Drug Therapy 2 Diathermy 2 Cytoreduction Surgical Procedures 2 Bevacizumab 2 squalamine lactate 1 sodium sulfate 1 poly ICLC 1 pembrolizumab 1 pamiparib 1 mirvetuximab soravtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04015739 2022-08-17

BOLD

ARCAGY/ GINECO GROUP

Phase 2 Unknown

Carcinoma, Ovarian Epithelial, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡